Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuang Ding

Showing results (231-240 of 235) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 235 results.
The Journal of Pharmacology and Experimental Therapeutics|May 18, 2004
Pharmacology of the urotensin-II receptor antagonist palosuran (ACT-058362; 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea sulfate salt): first demonstration of a pathophysiological role of the urotensin SystemMartine Clozel, Christoph Binkert, Magdalena Birker-Robaczewska, et al.
Communications Medicine|April 29, 2025
Preclinical characterization of an active immunotherapy targeting calcitonin gene-related peptideJustin D Boyd, Shixia Wang, Hsiao-Wen Lin, et al.
Nature Medicine|June 20, 2024
Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trialPepijn Eijsvogel, Pinaki Misra, Luis Concha-Marambio, et al.
Emerging Microbes & Infections|October 26, 2022
A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2Shixia Wang, Chang Yi Wang, Hui-Kai Kuo, et al.
The Journal of Clinical Investigation|March 22, 2022
A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variantsChang Yi Wang, Kao-Pin Hwang, Hui-Kai Kuo, et al.
Pageof 24

Showing results (231-240 of 235) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 235 results.
The Journal of Pharmacology and Experimental Therapeutics|May 18, 2004
Pharmacology of the urotensin-II receptor antagonist palosuran (ACT-058362; 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea sulfate salt): first demonstration of a pathophysiological role of the urotensin SystemMartine Clozel, Christoph Binkert, Magdalena Birker-Robaczewska, et al.
Communications Medicine|April 29, 2025
Preclinical characterization of an active immunotherapy targeting calcitonin gene-related peptideJustin D Boyd, Shixia Wang, Hsiao-Wen Lin, et al.
Nature Medicine|June 20, 2024
Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trialPepijn Eijsvogel, Pinaki Misra, Luis Concha-Marambio, et al.
Emerging Microbes & Infections|October 26, 2022
A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2Shixia Wang, Chang Yi Wang, Hui-Kai Kuo, et al.
The Journal of Clinical Investigation|March 22, 2022
A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variantsChang Yi Wang, Kao-Pin Hwang, Hui-Kai Kuo, et al.
Pageof 24